-transparent.png){kind=logo}
99mTc ethoxy methylpropyl isonitrile: a radioactive tracer for myocardial perfusion imaging. 1989
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
Medical Faculty, University of the Orange Free State, Bloemfontein, South Africa.
The initial experience with a new 99mTc labelled myocardial perfusion agent, ethoxy methylpropyl isonitrile (EMI), is described in the primate as model. Rapid biliary clearance of EMI ensures low radionuclide concentration in the liver and lungs after 60 min. Adequate visualization of the myocardium is therefore possible. Heart-to-lung and heart-to-liver ratios of 1.52 and 2.45 respectively were obtained. EMI is an efficient imaging agent to evaluate myocardial ischemia and infarction.
Related Publications
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
February 2005,
Nuclear medicine communications,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
December 1991,
Current opinion in radiology,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
August 1990,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
January 2005,
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
November 1989,
Circulation,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
February 1988,
Circulation,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
November 1996,
Nuclear medicine and biology,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
January 1992,
Journal of nuclear biology and medicine (Turin, Italy : 1991),
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
January 2019,
Current radiopharmaceuticals,
A van Aswegen, and
A J van Wyk, and
C P Herbst, and
A C Otto, and
A Viviers, and
J Koekemoer, and
O Knoesen, and
M G Lötter, and
P C Minnaar, and
P H Kleynhans
September 1991,
Circulation,
